The Global Nasal Drug Delivery Technology Market is estimated at $44,385 m in 2019 and is expected to grow at a CAGR of 7.8% from 2020-2025. In 2019, the Global Nasal Drug Delivery Technology Market was dominated by the nasal sprays submarket which held 33.2% of the overall market.

How this report will benefit you
  • Read on to discover how you can exploit the future business opportunities emerging in this sector.
  • In this brand new 185-page report you will receive 54 charts– all unavailable elsewhere.
  • The 185-page report provides clear detailed insight into the Global Nasal Drug Delivery Technology Market. Discover the key drivers and challenges affecting the market.
  • By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope
  • Revenue and growth forecasts from 2020 to 2030 for the Global Nasal Drug Delivery Technology Market by the dosage form:
  • Dosage Form: Nasal Sprays, Nasal Drops & Liquids, Nasal Gels, Nasal Powders
  • Nasal Sprays: Non-pressurized Containers and Pressurized Containers

Revenue and growth forecasts from 2020 to 2030 for the Global Nasal Drug Delivery Technology Market by System:
  • Nasal Unidose Devices
  • Nasal Bi Dose Devices
  • Nasal Multi Dose Devices

Revenue and growth forecasts from 2020 to 2030 for the Global Nasal Drug Delivery Technology Market by Application:
  • Asthma
  • Allergic and Non-Allergic Rhinitis
  • Nasal Congestion

Revenue and growth forecasts from 2020 to 2030 for the Global Nasal Drug Delivery Technology Market by End User:
  • Hospitals
  • Ambulatory Surgery Center
  • Specialty Clinics
  • Vaccination Centers

Revenue and growth forecasts from 2020 to 2030 for the leading national markets:
  • United States
  • Canada
  • Brazil
  • Mexico
  • Rest of Latin America
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Nordic
  • Benelux
  • Rest of Western Europe
  • Russia
  • Poland
  • Rest of Eastern Europe
  • Japan
  •  China
  • India
  • Australia & New Zealand
  • ASEAN
  • Rest of Asia-Pacific

GCC Countries
  • South Africa
  • North Africa
  • Rest of MEA

This report profiles the leading companies that market nasal drug delivery devices:
  • 3M Company
  • Becton, Dickinson and Company
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Teleflex Incorporated
  • Naveh Pharma Ltd.
  • OptiNose US, Inc.
  • Pendopharm
  • AptarGroup, Inc.